Bupivacaine and Epinephrine Injection Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2025

Conditions
Sinus DiseaseAnesthesiaBleeding
Interventions
DRUG

Sensorcaine with Epinephrine

The combination contains 0.25% bupivacaine hydrochloride (2.5 mg/mL) and epinephrine bitartrate \[(1:200,000) 5 mcg/mL\] per vial.

OTHER

Sham injection

Punctures without any medication injected onto the septum

Trial Locations (1)

V6Z 1Y6

RECRUITING

St.Paul's Hospital Sinus Center, Vancouver

All Listed Sponsors
lead

Amin Javer

OTHER